InfectiousICD-10: A49.02Causes over 80,000 invasive infections and 11,000 deaths annually in the U.S.

MRSA (Methicillin-Resistant Staphylococcus Aureus)

Also known as: MRSA, Staph Infection, Superbug, Antibiotic-Resistant Staph

MRSA is a type of Staphylococcus aureus bacteria that has developed resistance to methicillin and many other commonly used antibiotics, making infections more difficult to treat than standard staph infections. MRSA infections range from minor skin infections presenting as boils or abscesses to life-threatening bloodstream infections, pneumonia, and surgical site infections. MRSA can be classified as healthcare-associated (HA-MRSA), typically occurring in hospitals and long-term care facilities, or community-associated (CA-MRSA), which affects otherwise healthy individuals in community settings.

Last updated November 10, 2026

Understanding MRSA (Methicillin-Resistant Staphylococcus Aureus)

MRSA is Staphylococcus aureus that has acquired a gene, mecA, which lets it build its cell wall even in the presence of methicillin, penicillins, cephalosporins and most other beta-lactam antibiotics. That makes it harder to treat, not more aggressive by itself, although the dominant community strain in the United States (USA300) carries extra toxins that make it unusually good at forming abscesses. About 30 percent of people carry ordinary S. aureus in the nose and roughly 2 percent carry MRSA without any symptoms. Infection is far less common than carriage but still frequent: the CDC's most recent national count found 119,247 S. aureus bloodstream infections and 19,832 deaths in 2017, close to half of them MRSA, and an estimated 323,700 MRSA cases among hospitalized patients that year. Hospital-onset MRSA bloodstream infections fell by about 17 percent a year between 2005 and 2012, then the decline stalled, while community skin infections, which never enter those counts, remain common in gyms, locker rooms, barracks, prisons and households.

MRSA lives on skin and in the nose, and infection usually starts when it gets through a break: a shaved follicle, a scrape, a turf burn, an injection site, a surgical wound. In the skin it forms a boil or abscess, a walled-off pocket of pus that antibiotics penetrate poorly, which is why drainage, not a prescription, is the core treatment. From there it can spread as cellulitis or, far less often, seed the bloodstream and settle on heart valves, bones, joints or the lungs; MRSA bloodstream infection kills roughly one in five people even with the best antibiotics. Carriage matters because it predicts infection: people who carry MRSA are several times more likely to develop an infection in the following year, and after a first community skin infection between about 30 and 50 percent of people have another within 12 months, often from re-exposure within the household, where the organism survives for weeks on towels, bedding, razors and sports gear.

The Infectious Diseases Society of America guideline on MRSA makes incision and drainage the primary treatment for an abscess, with antibiotics added when there is surrounding cellulitis, fever, several sites, an abscess that is hard to drain fully, a weakened immune system, or no improvement after drainage. Two large trials have since nudged practice toward adding an antibiotic more often. In a 2016 trial of 1,247 people with drained abscesses, 7 days of trimethoprim-sulfamethoxazole raised the chance of being healed at follow-up from 74 to 81 percent and roughly halved repeat drainage, new infections at other sites and infections in household members. A 2017 trial of 786 people with smaller abscesses found clindamycin and trimethoprim-sulfamethoxazole each produced resolution in about 82 percent versus 69 percent with placebo. Serious infections get intravenous vancomycin, daptomycin, linezolid or ceftaroline, usually for 2 to 6 weeks. For people with repeated infections, a 2019 trial of 2,121 MRSA carriers leaving hospital found that 6 months of twice-monthly chlorhexidine washes, chlorhexidine mouthwash and nasal mupirocin reduced MRSA infections by 30 percent.

No herb, oil or supplement treats a MRSA infection, and the search for one wastes the days in which a small abscess becomes cellulitis or a bloodstream infection. Colloidal silver, oregano oil, garlic and manuka honey kill MRSA in a dish, which is where the evidence stops; silver also causes permanent grey-blue skin discoloration (argyria). Tea tree oil is the only topical with trials in people: in the largest, a tea tree nasal cream and body wash cleared carriage in 41 percent of 236 carriers versus 49 percent with mupirocin and chlorhexidine, and a later intensive-care trial found a tea tree body wash did not prevent colonization. A probiotic taken with clindamycin or another broad antibiotic reduces the risk of Clostridioides difficile diarrhea by about 60 percent, an oral Bacillus subtilis spore probiotic cut S. aureus gut carriage by 97 percent and nasal carriage by 65 percent in one 115-person trial, and correcting a low vitamin D is sensible for skin and immune function, although a year of 4,000 IU did not clear carriage in persistent carriers.

The most common mistake is squeezing or lancing a boil at home with a needle, a pin or a razor. Pressure pushes pus into surrounding tissue and the bloodstream, a dirty blade adds a second infection, and a cut that is not opened properly re-seals and refills; clinicians drain abscesses with a sterile blade, break up the internal pockets and sometimes pack the cavity for a reason. Warm compresses for 10 to 15 minutes several times a day can bring a small boil to a head and let it drain on its own, but anything larger than about 2 cm, anything on the face, spine or groin, or anything with spreading redness, red streaks, fever or severe pain needs to be seen within 24 hours. The second mistake is finishing the antibiotic and dropping the hygiene: the household measures (separate towels, hot washing, daily showering, covered wounds, decolonization of everyone at home) are what stop the fourth and fifth infection.

At a Glance

Common symptoms
Red, swollen, and painful skin bumps resembling pimples or spider bites, Warm, pus-filled abscesses that may need drainage, Fever accompanying skin infection
Main treatments
Incision and drainage of abscesses (may be sufficient for small skin infections), Antibiotics effective against MRSA: trimethoprim-sulfamethoxazole, doxycycline, or clindamycin for skin infections, Intravenous vancomycin, daptomycin, or linezolid for serious systemic infections
Category
Infectious · Causes over 80,000 invasive infections and 11,000 deaths annually in the U.S.
See a doctor if
A skin infection does not improve or worsens despite antibiotic treatment

Symptoms

Red, swollen, and painful skin bumps resembling pimples or spider bites
Warm, pus-filled abscesses that may need drainage
Fever accompanying skin infection
Wound infections that do not respond to standard antibiotics
Cellulitis with rapidly spreading redness
Pneumonia symptoms in healthcare-associated MRSA (cough, shortness of breath, fever)
Signs of sepsis in severe cases: high fever, rapid heart rate, low blood pressure

Causes

  • Staphylococcus aureus bacteria that have acquired the mecA gene for antibiotic resistance
  • Overuse and misuse of antibiotics driving resistance selection
  • Direct contact with an infected wound or contaminated surfaces
  • Colonization of MRSA on the skin or in the nasal passages without active infection

Risk Factors

  • Hospitalization, surgery, or residence in a long-term care facility
  • Invasive devices such as IV lines, urinary catheters, or ventilators
  • Weakened immune system from HIV, cancer treatment, or organ transplant
  • Close contact sports with skin-to-skin contact (wrestling, football)
  • Crowded living conditions (military barracks, dormitories, prisons)
  • Open wounds, cuts, or skin abrasions

Diagnosis

  • Wound culture and sensitivity testing to identify MRSA and determine effective antibiotics
  • Nasal swab screening for MRSA colonization in hospital settings
  • Blood cultures for suspected bloodstream infections
  • PCR-based rapid diagnostic testing for fast MRSA identification

Treatment

  • Incision and drainage of abscesses (may be sufficient for small skin infections)
  • Antibiotics effective against MRSA: trimethoprim-sulfamethoxazole, doxycycline, or clindamycin for skin infections
  • Intravenous vancomycin, daptomycin, or linezolid for serious systemic infections
  • Wound care and monitoring for treatment response
  • Decolonization protocols (mupirocin nasal ointment, chlorhexidine body wash) for recurrent MRSA
  • Surgical debridement for deep tissue or bone infections

Natural remedies for mrsa (methicillin-resistant staphylococcus aureus): what the evidence says

Ranked by the strength of human evidence for mrsa (methicillin-resistant staphylococcus aureus) specifically. These sit alongside medical care, not in place of it.

  1. A 2017 Cochrane review of 31 trials (8,672 adults and children) found that a probiotic taken alongside antibiotics reduced the risk of Clostridioides difficile diarrhea by 60 percent, from 4.0 to 1.5 percent, with the benefit concentrated in people whose baseline risk was above 5 percent, such as hospital patients. This matters for MRSA because clindamycin, one of the standard oral choices for skin infections, is among the antibiotics most strongly linked to C. difficile. Probiotics do nothing to the staph itself.

    Studied dose
    A Lactobacillus rhamnosus GG or multi-strain Lactobacillus product at 10 to 20 billion CFU daily, started with the first antibiotic dose, taken 2 hours apart from it, and continued for a week after the course ends.
    Cautions
    Avoid in people with a central venous catheter, severe immune suppression, pancreatitis or critical illness, where probiotic bloodstream infections have been reported. Otherwise mild bloating is the main side effect.
  2. Tea Tree Oil

    Preliminary evidence

    In the largest trial, 236 hospital patients colonized with MRSA were randomized to a 10 percent tea tree oil nasal cream plus 5 percent tea tree body wash, or to mupirocin nasal ointment plus chlorhexidine wash, for 5 days. Carriage was cleared in 41 percent of the tea tree group and 49 percent of the standard group, a difference that was not significant; tea tree did worse in the nose but somewhat better at clearing skin sites. A 2013 trial of 445 intensive-care patients found a 5 percent tea tree body wash did not reduce new MRSA colonization. No trial shows tea tree oil treats an established abscess or cellulitis.

    Studied dose
    5 percent tea tree oil body wash daily plus 10 percent tea tree cream applied inside the nostrils three times daily for 5 days, as used in the decolonization trial; never undiluted on broken skin.
    Cautions
    Causes allergic contact dermatitis in a few percent of users, more often when the oil has oxidized in light and air. It is poisonous if swallowed, has been linked to breast tissue growth in prepubertal boys with repeated use, and is toxic to cats and dogs. It is not a replacement for drainage or antibiotics.
  3. In a 2023 placebo-controlled trial in Thailand, 115 healthy adults who carried S. aureus took Bacillus subtilis spores or placebo daily for 30 days. Fecal S. aureus counts fell by 96.8 percent and nasal counts by 65.4 percent in the probiotic group, with no change in the rest of the gut microbiome; the spores block the quorum-sensing signal staph uses to colonize. Most carriers in the trial had methicillin-susceptible strains and the outcome was carriage, not infection, so this is a promising single study rather than a proven prevention strategy.

    Studied dose
    250 mg of Bacillus subtilis spores (about 4 billion CFU) once daily for 30 days.
    Cautions
    Bacillus species have caused bloodstream infections in people with central lines or severe immune suppression, so avoid them in hospital and in anyone immunocompromised. Not a substitute for mupirocin and chlorhexidine decolonization when a clinician recommends it.
  4. Vitamin D

    Preliminary evidence

    In US national survey data, adults with vitamin D deficiency were nearly twice as likely to carry MRSA in the nose, and low vitamin D has been linked to more frequent skin infections in several cohorts. The one randomized trial, in 65 persistent MRSA carriers given 4,000 IU daily or placebo for 12 months, found no difference in eradication. Correcting a deficiency is reasonable for general skin and immune health, but it does not treat or clear MRSA.

    Studied dose
    1,000 to 2,000 IU vitamin D3 daily, or a dose guided by a vitamin D blood test if you are deficient.
    Cautions
    Doses above 4,000 IU daily without monitoring can raise blood calcium, especially with thiazide diuretics or in sarcoidosis and other granulomatous disease. Check a level rather than guessing.

What matters day to day

  • Keep any draining wound covered with a clean, dry dressing and change it as soon as it soaks through: drainage is the most infectious material, and a covered wound is the single measure the CDC rates highest for stopping spread at home, at school and in sport.
  • Shower straight after practice or a match and never share towels, razors, bar soap or uniforms: in a college football outbreak, body shaving raised the odds of MRSA infection about 6-fold and turf burns about 7-fold, because both open the skin.
  • Wash towels, sheets and clothing that touch a wound in hot water with detergent and dry on high heat: staph survives on fabric for weeks, and the dryer's heat does more than the wash cycle.
  • Clean hands with soap for 20 seconds or an alcohol gel before and after touching a wound or dressing: hands are how MRSA moves from one person's boil to another person's scrape, and alcohol gel kills MRSA as readily as ordinary staph.
  • Do not pick, scratch or shave over bumps: the hair follicle is the entry point, and shaving a colonized area opens hundreds of them at once; if you must remove hair, use clippers rather than a razor.
  • After two or more infections in a year, ask about household decolonization: in a trial of 183 households, five days of nasal mupirocin and chlorhexidine washes for everyone at home cut recurrence at 12 months from 72 to 52 percent compared with treating the patient alone.

Prevention

  • Wash hands frequently with soap and water or use alcohol-based hand sanitizer
  • Keep cuts, scrapes, and wounds clean, covered, and bandaged
  • Avoid sharing personal items such as towels, razors, and athletic equipment
  • Clean and disinfect surfaces and equipment that may be contaminated
  • Complete the full course of prescribed antibiotics to prevent resistance
  • Shower after contact sports and athletic activities

When to See a Doctor

  • A skin infection does not improve or worsens despite antibiotic treatment
  • You develop a painful, red, swollen, and warm area of skin with pus
  • You have a fever along with skin infection or wound that is not healing
  • You have been in a hospital or care facility and develop signs of infection

Frequently Asked Questions

References

  1. Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical Infectious Diseases (2011)
  2. Talan DA, Mower WR, Krishnadasan A, et al.. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. New England Journal of Medicine (2016)
  3. Daum RS, Miller LG, Immergluck L, et al.. A placebo-controlled trial of antibiotics for smaller skin abscesses. New England Journal of Medicine (2017)
  4. Huang SS, Singh R, McKinnell JA, et al.. Decolonization to reduce postdischarge infection risk among MRSA carriers. New England Journal of Medicine (2019)
  5. Kourtis AP, Hatfield K, Baggs J, et al.. Vital Signs: epidemiology and recent trends in methicillin-resistant and methicillin-susceptible Staphylococcus aureus bloodstream infections, United States. MMWR Morbidity and Mortality Weekly Report (2019)
  6. Fritz SA, Hogan PG, Hayek G, et al.. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clinical Infectious Diseases (2012)
  7. Dryden MS, Dailly S, Crouch M. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. Journal of Hospital Infection (2004)
  8. Piewngam P, Khongthong S, Roekngam N, et al.. Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial. Lancet Microbe (2023)
  9. Goldenberg JZ, Yap C, Lytvyn L, et al.. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews (2017)
  10. MedlinePlus, National Library of Medicine. MRSA (2024)View source

Related Conditions

Have questions about MRSA (Methicillin-Resistant Staphylococcus Aureus)?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.